| Application no. and date | 99971703.6 (espacenet) (Federated) (European Patent Register), 19991103 | | Patent/reg. no. and date | DK/EP 1124539, 20030702 | | Publication date | 20010822 | | Priority no. and date | SE 9803772, 19981105 | | EP pub. no. and date |
EP 1124539 20010822 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | | | Inventor | BERGSTRAND, Pontus, AstraZeneca R&D Mölndal
S-431 83 Mölndal, SE,
WANG, Peter, AstraZeneca R&D Mölndal
S-431 83 Mölndal, SE | | Representative | | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 47/38 (2006.01) , A61K 9/24 (2006.01) | | Title | Farmaceutisk formulering der omfatter omeprazol | | Int. application no. | SE1999001989 | | Int. publication no. | WO2000027366 | | Related patent (certificate) | | | Status | Afkaldt | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
